CH384567A - Process for the preparation of new benzophenone sulfonamides - Google Patents
Process for the preparation of new benzophenone sulfonamidesInfo
- Publication number
- CH384567A CH384567A CH1006863A CH1006863A CH384567A CH 384567 A CH384567 A CH 384567A CH 1006863 A CH1006863 A CH 1006863A CH 1006863 A CH1006863 A CH 1006863A CH 384567 A CH384567 A CH 384567A
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- benzophenone
- chloro
- molecular weight
- low molecular
- Prior art date
Links
- -1 benzophenone sulfonamides Chemical class 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 5
- 229940124530 sulfonamide Drugs 0.000 title description 30
- 239000012965 benzophenone Substances 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims description 17
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 7
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 4
- 150000002431 hydrogen Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000005111 carboxyalkoxy group Chemical group 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 229960001173 oxybenzone Drugs 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 239000012954 diazonium Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
- 230000029142 excretion Effects 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 150000001989 diazonium salts Chemical class 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FJZOQLFYOJOGMR-UHFFFAOYSA-N 2-(4-chlorobenzoyl)-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=CC=C1C(=O)C1=CC=C(Cl)C=C1 FJZOQLFYOJOGMR-UHFFFAOYSA-N 0.000 description 1
- HVFIATGAEYKQSJ-UHFFFAOYSA-N 2-[4-(4-chlorobenzoyl)phenoxy]acetamide Chemical compound C1=CC(OCC(=O)N)=CC=C1C(=O)C1=CC=C(Cl)C=C1 HVFIATGAEYKQSJ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KWSLGOVYXMQPPX-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenyl]-2h-tetrazole Chemical compound FC(F)(F)C1=CC=CC(C2=NNN=N2)=C1 KWSLGOVYXMQPPX-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical group [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- IVDPWEKOUUEEBD-UHFFFAOYSA-N potassium;copper(1+);dicyanide Chemical compound [K+].[Cu+].N#[C-].N#[C-] IVDPWEKOUUEEBD-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229910001379 sodium hypophosphite Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical class OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung neuer Benzophenonsulfonamide
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung neuer Benzophenonsulfonamide mit wertvollen pharmakologischen Eigenschaften.
Es wurde überraschenderweise gefunden, dass Benzophenonsulfonamide der Formel
EMI1.1
worin R, ein Halogenatom, eine Aminogruppe oder eine niedermolekulare Alkyl-oder Alkoxygruppe, Rz Wasserstoff, ein Halogenatom, eine niedermolekulare Alkoxygruppe, eine Carboxyl-oder Carbalkoxygruppe, eine unsubstituierte oder durch niedermolekulare Alkyl-, Alkenyl-, Hydroxyalkyl-oder Polymethylenreste oder den 3-Oxapentylen- (1, 5)-rest substituierte Sulfamyl-, Carbamyl-oder Carbamylalkoxygruppe, oder eine Carboxy-alkoxygruppe, R3 dasselbe wie R2 oder eine Alkanoylamino-oder Nitrogruppe, wobei unsubstituierte und monosubstituierte Carbamylgruppen, sofern vorhanden,
sich in m-oder p-Stellung zur-CO-Gruppe befinden, R4 Wasserstoff, ein Halogenatom oder eine niedermolekulare Alkoxygruppe bedeuten, eine ausgezeichnete diuretische Wirksamkeit besitzen. Hierbei ist das gegenseitige Verhältnis der ausgeschiedenen Ionen manche therapeutische Zwecke sehr günstig, indem beispielsweise die Kaliumausscheidung im Vergleich zur Natriumausscheidung relativ gering ist, und anderseits der starken Natriumausscheidung auch eine beträchtliche Vermehrung der Chlor-und Wasserausscheidung gegenübersteht. Teilweise eignen sich die oben definierten Verbindungen auch als Zwischenprodukte für die Herstellung weiterer diuretisch wirksamer Stoffe.
Man stellt die weiter oben definierten Verbin- dungen her, indem man Verbindungen der Formel
EMI1.2
mit oxydierenden Mitteln, z.
B. mit Kaliumpermanganatlösung, behandelt. Ausgangsstoff der Formel II ist z. B. das 3-Sulfamyl-4-chlor-diphenylmethan.
Diese und weitere Verbindungen der Formel II kön- nen beispielsweise aus den entsprechenden 4-substituierten 3-Halogensulfonyldiphenylmethanen durch Umsetzung mit Ammoniak hergestellt werden.
In erfindungsgemäss erhaltenen Verbindungen können weitere Substituenten eingeführt oder vorhandene in andere umgewandelt werden. Insbesondere kann man Verbindungen der Formel I, worin R3 durch eine Nitrogruppe, oder Rs undoder Ri durch Aminogruppen, verkörpert sind, in andere unter die Formel I fallende Verbindungen umwandeln. Beispielsweise können Verbindungen der Formel I, worin R3 durch eine Nitrogruppe verkörpert ist, während Ri, R2 und R4 die oben angegebene Bedeutung haben, zu Verbindungen mit einer Aminogruppe R3 reduziert werden.
Solche Verbindungen sowie Verbindungen mit einer Aminogruppe Rl können in Diazoniumsalze übergeführt werden, die nach den verschiedenen an sich bekannten Methoden weiter umgesetzt werden können.
Genannt seien hier beispielsweise die Umwandlung der Diazoniumhalogenide in entsprechende Halogenverbindungen (R3 undloder Rt = Halogen, insbesondere Chlor) oder in Cyanverbindungen durch Behandlung ihrer Lösungen mit Cuprohalogenid, Kupferpulver bzw. Kaliumcuprocyanid, das Zersetzen von Diazoniumsalzen, z. B. Sulfaten, mit niedermolekularen Alkanolen zu Alkoxyverbindungen (R3 und/oder Ri = Alkoxygruppen) und der Ersatz der Diazoniumgruppe durch Wasserstoff durch Behandlung der Diazoniumsalze mit wässriger Natrium hypophosphitlösung, mit AmeisensÏure, Formamid, Dimethylformamid oder einem Alkohol.
Alle vorgenannten Umwandlungsprodukte mit Ausnahme der Cyanoverbindungen fallen wiederum unter die Formel I ; durch partielle oder vollständige Hydrolyse der Cyanoverbindungen erhält man indessen ebenfalls unter die Formel I fallende Verbindungen mit einer Carbamyl-bzw. Carboxylgruppe R3 bzw. R2. Im weiteren kann man geeignete Diazo niumchloride von Verbindungen der Formel I durch Behandlung mit Schwefeldioxyd in Sulfochloride überführen und letztere mit Ammoniak oder geeigneten aliphatischen Aminen, das heisst niedermolekularen Mono-und Dialkylaminen, Monoalkanol- aminen, Dialkanolaminen, N-Alkyl-alkanolaminen oder mit Pyrrolidin, Piperidin oder Morpholin zu Verbindungen mit einer gegebenenfalls substituierten Sulfamylgruppe R2 umsetzen.
Im nachfolgenden Beispiel bedeuten Teile Gewichtsteile ; diese verhalten sich zu Volumteilen wie g zu cm3. Die Temperaturen sind in Celsiusgraden angegeben.
Beispiel
32, 6 Teile des 4-Chlor-2'-carboxy-diphenylmethan-3-sulfonamids (Smp. 194, 5 ), das sich durch Reduktion von 4-Chlor-3-amino-benzophenon-2'- carbonsäure mit Zinkstaub und Ammoniak aber- führen der Aminogruppe in die Sulfamylgruppe durch Diazotieren und Zersetzen des Diazoniumhalogenids mit Schwefeldioxyd in Gegenwart von Kupfersalzen, wie Kupferchlorid, leicht herstellen lässt, werden in 400 Teilen figer Natronlauge gelöst und bei 90 bis 95 durch allmähliche Zugabe von 520 Teilen einer 5 loigen wässrigen Lösung von Kaliumpermanganat oxydiert. Nach Zugabe von wenig Natriumbisulfit wird der abgeschiedene Braunstein abfiltriert.
Aus dem Filtrat wird durch Ansäuern mit Salzsäure das 4-Chlor-2'-carboxy-benzophenon-3-sulfonamid ausgefällt. Der Schmelzpunkt liegt nach mehrmaliger Umkristallisation aus Wasser bei 2230.
In analoger Weise werden erhalten :
4-Chlor-benzophenon-3, 4'-disulfonamid,
Smp. 201-202 .
4-Chlor-benzophenon-3, 3'-disulfonamid,
Smp. 236 .
4-Brom-benzophenon-3, 4'-disulfonamid,
Smp. 229, 5 .
4, 4'-Dichlor-benzophenon-3, 3'-disulfonamid,
Smp. 237 .
4, 4'-Dibrom-benzophenon-3, 3'-disulfonamid,
4, 4'-Difluor-benzophenon-3, 3'-disulfonamid, 4-Chlor-4'-methoxy-benzophenon-3-sulfonamid,
Smp. 161 .
4, 4'-Dimethoxy-benzophenon-3,3'-disulfonamid,
Smp. 292 .
4-Chlor-äthoxy-benzophenon-3'-sulfonamid,
Smp. 161 .
4-Chlor-2'-carboxymethoxy-benzophenon-
3-sulfonamid, Smp. 178, 5-182j.
4-Chlor-2'-carbäthoxy-benzophenon-
3-sulfonamid, Smp. 150, 5-153 .
4-Chlor-2'-carbamylmethoxy-benzophenon-
3-sulfonamid, 4-Chlor-2'-diäthylcarbamylmethoxy-benzo- phenon-3-sulfonamid, 4-Chlor-2'-diallylcarbamylmethoxy-benzo- phenon-3-sulfonamid, 4-Chlor-4 !-carbamyl-benzophenon-3-sulfonamid,
Smp. 244-247 .
4-Chlor-4'-carboxy-methoxy-benzophenon
3-sulfonamid, Smp. 191-193, 5w.
4-Chlor-4'-carbamylmethoxy-benzophenon
3-sulfonamid, Smp. 233-237¯.
4-Chlor-4'-dimethylcarbamylmethoxy-benzo- phenon-3-sulfonamid, Smp. 144, 5-147 .
4-Chlor-4'-(ss-carbamyl-äthoxy)-benzophenon-
3-sulfonamid,
4-Chlor-4'-(ss-diäthylcarbamyl-äthoxy)-benzo- phenon-3-sulfonamid,
4-Chlor-3'-äthylsulfamyl-benzophenon-3-sulfon- amid, Smp. 231-232 .
4-Chlor-3'-äthylsulfamyl-benzophenon-3-sulfon- amid, Smp. 213 .
4-Chlor-3'-diäthylsulfamyl-benzophenon-
3-sulfonamid, Smp. 163 .
4-Chlor-3'-sulfonsäurepiperidid-benzophenon-
3-sulfonamid, 4-Chlor-3'-sulfonsäuremorpholid-benzophenon-
3-sulfonamid,
4-Chlor-3'-i-hydroxy-äthylsulfamyl-benzophenon-
3-sulfonamid, Smp. 149 .
4-Chlor-3'-carboxyl-4'-n-propoxy-benzophenon-
3-sulfonamid, Smp. 188 .
4-Chlor-4'-carboxy-benzophenon-3-sulfonamid,
Smp. 272-278, 50.
4-Chlor-3'-nitro-4'-carboxy-benzophenon
3-sulfonamid, Smp. 213-215 .
4-Chlor-2'-dimethylcarbamyl-benzophenon
3-sulfonamid, Smp. 173-175¯.
4-Chlor-2'-diäthylcarbamyl-benzophenon-
3-sulfonamid, Smp. 202-204 .
Process for the preparation of new benzophenone sulfonamides
The present invention relates to a process for the preparation of new benzophenone sulfonamides with valuable pharmacological properties.
It has surprisingly been found that benzophenone sulfonamides of the formula
EMI1.1
where R, a halogen atom, an amino group or a low molecular weight alkyl or alkoxy group, Rz hydrogen, a halogen atom, a low molecular weight alkoxy group, a carboxyl or carbalkoxy group, an unsubstituted or low molecular weight alkyl, alkenyl, hydroxyalkyl or polymethylene radical or the 3 -Oxapentylene (1,5) radical substituted sulfamyl, carbamyl or carbamylalkoxy group, or a carboxyalkoxy group, R3 the same as R2 or an alkanoylamino or nitro group, with unsubstituted and monosubstituted carbamyl groups, if present,
are in the m or p position to the -CO group, R4 is hydrogen, a halogen atom or a low molecular weight alkoxy group, have excellent diuretic activity. Here, the mutual ratio of the ions excreted is very favorable for some therapeutic purposes, in that, for example, the potassium excretion is relatively low compared to the sodium excretion and, on the other hand, the strong sodium excretion is offset by a considerable increase in the chlorine and water excretion. Some of the compounds defined above are also suitable as intermediates for the preparation of further diuretically active substances.
The compounds defined above are prepared by adding compounds of the formula
EMI1.2
with oxidizing agents, e.g.
B. with potassium permanganate solution treated. Starting material of formula II is z. B. 3-sulfamyl-4-chloro-diphenylmethane.
These and other compounds of the formula II can be prepared, for example, from the corresponding 4-substituted 3-halosulfonyldiphenylmethanes by reaction with ammonia.
In compounds obtained according to the invention, further substituents can be introduced or existing ones can be converted into others. In particular, compounds of the formula I in which R3 is represented by a nitro group, or Rs and / or Ri by amino groups, can be converted into other compounds falling under the formula I. For example, compounds of the formula I in which R3 is represented by a nitro group, while Ri, R2 and R4 have the meaning given above, can be reduced to compounds with an amino group R3.
Such compounds and compounds with an amino group Rl can be converted into diazonium salts which can be further reacted by various methods known per se.
Examples include the conversion of the diazonium halides into corresponding halogen compounds (R3 undloder Rt = halogen, especially chlorine) or in cyano compounds by treating their solutions with cuprous halide, copper powder or potassium cuprocyanide, the decomposition of diazonium salts, e.g. B. sulfates, with low molecular weight alkanols to alkoxy compounds (R3 and / or Ri = alkoxy groups) and the replacement of the diazonium group by hydrogen by treating the diazonium salts with aqueous sodium hypophosphite solution, with formic acid, formamide, dimethylformamide or an alcohol.
All of the aforementioned conversion products, with the exception of the cyano compounds, again fall under the formula I; by partial or complete hydrolysis of the cyano compounds, however, compounds falling under the formula I with a carbamyl or. Carboxyl group R3 or R2. In addition, suitable diazonium chlorides of compounds of the formula I can be converted into sulfochlorides by treatment with sulfur dioxide, and the latter with ammonia or suitable aliphatic amines, that is to say low molecular weight mono- and dialkylamines, monoalkanolamines, dialkanolamines, N-alkylalkanolamines or with pyrrolidine , Piperidine or morpholine to form compounds with an optionally substituted sulfamyl group R2.
In the following example, parts are parts by weight; these are related to parts of volume as g to cm3. The temperatures are given in degrees Celsius.
example
32.6 parts of 4-chloro-2'-carboxy-diphenylmethane-3-sulfonamide (melting point 194, 5), which is obtained by reducing 4-chloro-3-aminobenzophenone-2'-carboxylic acid with zinc dust and ammonia but lead the amino group into the sulfamyl group by diazotizing and decomposing the diazonium halide with sulfur dioxide in the presence of copper salts, such as copper chloride, can be easily prepared, are dissolved in 400 parts of solid sodium hydroxide solution and at 90 to 95 by the gradual addition of 520 parts of a 5 loigen aqueous solution Solution of potassium permanganate oxidized. After adding a little sodium bisulfite, the precipitated manganese dioxide is filtered off.
The 4-chloro-2'-carboxy-benzophenone-3-sulfonamide is precipitated from the filtrate by acidification with hydrochloric acid. The melting point is 2230 after repeated recrystallization from water.
In an analogous way the following are obtained:
4-chloro-benzophenone-3, 4'-disulfonamide,
M.p. 201-202.
4-chloro-benzophenone-3, 3'-disulfonamide,
M.p. 236.
4-bromo-benzophenone-3, 4'-disulfonamide,
M.p. 229, 5.
4, 4'-dichloro-benzophenone-3, 3'-disulfonamide,
M.p. 237.
4,4'-dibromobenzophenone-3, 3'-disulfonamide,
4, 4'-difluoro-benzophenone-3, 3'-disulfonamide, 4-chloro-4'-methoxy-benzophenone-3-sulfonamide,
M.p. 161.
4,4'-dimethoxy-benzophenone-3,3'-disulfonamide,
M.p. 292.
4-chloro-ethoxy-benzophenone-3'-sulfonamide,
M.p. 161.
4-chloro-2'-carboxymethoxy-benzophenone-
3-sulfonamide, m.p. 178, 5-182j.
4-chloro-2'-carbethoxy-benzophenone-
3-sulfonamide, m.p. 150, 5-153.
4-chloro-2'-carbamylmethoxy-benzophenone-
3-sulfonamide, 4-chloro-2'-diethylcarbamylmethoxy-benzophenone-3-sulfonamide, 4-chloro-2'-diallylcarbamylmethoxy-benzophenone-3-sulfonamide, 4-chloro-4! -Carbamyl-benzophenone-3 -sulfonamide,
M.p. 244-247.
4-chloro-4'-carboxy-methoxy-benzophenone
3-sulfonamide, m.p. 191-193, 5w.
4-chloro-4'-carbamylmethoxy-benzophenone
3-sulfonamide, m.p. 233-237¯.
4-chloro-4'-dimethylcarbamylmethoxy-benzophenone-3-sulfonamide, m.p. 144, 5-147.
4-chloro-4 '- (ss-carbamyl-ethoxy) -benzophenone-
3-sulfonamide,
4-chloro-4 '- (ss-diethylcarbamyl-ethoxy) -benzo- phenone-3-sulfonamide,
4-chloro-3'-ethylsulfamyl-benzophenone-3-sulfonamide, m.p. 231-232.
4-chloro-3'-ethylsulfamyl-benzophenone-3-sulfonamide, m.p. 213.
4-chloro-3'-diethylsulfamyl-benzophenone-
3-sulfonamide, m.p. 163.
4-chloro-3'-sulfonic acid piperidide benzophenone
3-sulfonamide, 4-chloro-3'-sulfonic acid morpholide-benzophenone-
3-sulfonamide,
4-chloro-3'-i-hydroxy-ethylsulfamyl-benzophenone-
3-sulfonamide, m.p. 149.
4-chloro-3'-carboxyl-4'-n-propoxy-benzophenone-
3-sulfonamide, m.p. 188.
4-chloro-4'-carboxy-benzophenone-3-sulfonamide,
M.p. 272-278, 50.
4-chloro-3'-nitro-4'-carboxy-benzophenone
3-sulfonamide, m.p. 213-215.
4-chloro-2'-dimethylcarbamyl-benzophenone
3-sulfonamide, m.p. 173-175¯.
4-chloro-2'-diethylcarbamyl-benzophenone-
3-sulfonamide, m.p. 202-204.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1006863A CH384567A (en) | 1958-10-17 | 1958-10-17 | Process for the preparation of new benzophenone sulfonamides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1006863A CH384567A (en) | 1958-10-17 | 1958-10-17 | Process for the preparation of new benzophenone sulfonamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH384567A true CH384567A (en) | 1964-11-30 |
Family
ID=4358982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1006863A CH384567A (en) | 1958-10-17 | 1958-10-17 | Process for the preparation of new benzophenone sulfonamides |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH384567A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998032732A1 (en) * | 1997-01-28 | 1998-07-30 | F. Hoffmann-La Roche Ag | 5-aroylnaphthalene derivatives |
-
1958
- 1958-10-17 CH CH1006863A patent/CH384567A/en unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998032732A1 (en) * | 1997-01-28 | 1998-07-30 | F. Hoffmann-La Roche Ag | 5-aroylnaphthalene derivatives |
| FR2758818A1 (en) * | 1997-01-28 | 1998-07-31 | Hoffmann La Roche | 5-AROYLNAPHTHALENE DERIVATIVES WITH ANTI-INFLAMMATORY AND ANALGESIC ACTION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF USING AND PREPARING SAME |
| US5962531A (en) * | 1997-01-28 | 1999-10-05 | Syntex (U.S.A.) Inc. | 5-aroylnaphthalene derivatives as anti-inflammatory agents |
| ES2135351A1 (en) * | 1997-01-28 | 1999-10-16 | Hoffmann La Roche | DERIVATIVES OF 5-AROILNAFTALENO. |
| AU721407B2 (en) * | 1997-01-28 | 2000-07-06 | F. Hoffmann-La Roche Ag | 5-aroylnaphthalene derivatives |
| US6150397A (en) * | 1997-01-28 | 2000-11-21 | Syntex (U.S.A.) Inc. | 5-aroylnaphthalene derivatives as anti-inflammatory agents |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1040562B (en) | Process for the production of solid, durable diazonium compounds | |
| CH384567A (en) | Process for the preparation of new benzophenone sulfonamides | |
| DE2204974A1 (en) | ||
| AT356966B (en) | HERBICIDAL AGENT | |
| DE1273537B (en) | Process for the production of azoamides | |
| DE2444977A1 (en) | PROCESS FOR PRODUCING THIOCARBAMYL SULFENAMIDES | |
| AT236968B (en) | Process for the preparation of new substitution products of 2-halogen-3-mercaptoquinoxaline | |
| DE2631207A1 (en) | Prepn. of basic oxazine dyes - by condensn. and pptn. with urea or thiourea, with addn. of di:hydric alcohol | |
| AT219039B (en) | Process for the preparation of new isoindoline derivatives | |
| AT210873B (en) | Process for the preparation of disulfamylaniline compounds | |
| DD220841A1 (en) | METHOD FOR PRODUCING SUBSTITUTED PHENYL HYDRAZINES | |
| AT206431B (en) | Process for the preparation of disulfamylaniline compounds | |
| AT206430B (en) | Process for the preparation of disulfamylaniline compounds | |
| AT212302B (en) | Process for the production of new Benzophenonsulfonamiden | |
| DE2115463A1 (en) | Aqueous composition and method for preventing corrosion | |
| AT322564B (en) | PROCESS FOR THE PREPARATION OF NEW PYRIDOPYRIDAZINE DERIVATIVES AND THEIR PHARMACEUTICAL SALT | |
| AT204552B (en) | Process for the preparation of new, heterocyclic bis-sulfonamides | |
| AT257626B (en) | Process for the preparation of new sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxides and their salts | |
| AT218528B (en) | Process for the preparation of new, substituted 1, 2, 3, 4-benzothiatriazine-1, 1, -dioxydes | |
| AT318634B (en) | Process for the preparation of new 3-phenyl-4,5,6-trichloropyridazine | |
| AT67682B (en) | Process for making durable nitrobenzene diazonium compounds. | |
| CH638468A5 (en) | Process for reducing the colouring of aqueous waste solutions containing arylazo, arylnitro or metallised arylazo compounds | |
| AT246132B (en) | Process for the preparation of new 4-nitro-pyrazolecarboxylic acids | |
| AT228221B (en) | Process for the preparation of new sulfonylureas | |
| AT347441B (en) | PROCESS FOR THE PREPARATION OF NEW 3-THIOCYANATO-4-TRIFLUOROMETHYL-2,6 -DINITROANILINES |